Search for Terms or Answers
Gout is a metabolic and inflammatory disorder associated with increased cardiovascular risk and premature mortality, although causality has been uncertain.
When a patient with axial spondyloarthritis patient sits in your clinic, their joint inflammation is only half the story. To truly achieve disease control, one should ask: “Am I consistently and aggressively screening them all for cardiovascular risk?"
Weber et al: Ixekizumab + tirzepatide improved CV risk factors and calculated CV risk beyond ixekizumab alone in psoriatic disease with obesity. Not proven fewer CV events, but a powerful reason to look beyond joints. @rheumnow #ACR2026 #ACRBest Abstract#2299
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.